Tejnaksh Healthcare (BOM:539428) Stock Based Compensation: ₹0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539428 Tejnaksh Healthcare Ltd BOM:539428
68 GF Score
Price ₹13.25
GF Value ₹20.92
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Tejnaksh Healthcare Stock Based Compensation?

Tejnaksh Healthcare BOM:539428 +0.68% 68 Stock Based Compensation is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:539428 with a GF Score™ of 68/100 and a GF Value™ of ₹20.92 (Possible Value Trap). The stock has 4 warning signs investors should review.

Tejnaksh Healthcare's Stock Based Compensation for the three months ended in Mar. 2026 was ₹0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Tejnaksh Healthcare Stock Based Compensation Related Terms

Tejnaksh Healthcare Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Tejnaksh Healthcare's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tejnaksh Healthcare Stock Based Compensation Chart

Tejnaksh Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Tejnaksh Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:539428
68GF Score
Tejnaksh Healthcare Ltd BOM:539428
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tejnaksh Healthcare Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

What does a Stock Based Compensation of ₹0.0 Mil mean?
Tejnaksh Healthcare (BOM:539428) has a Stock Based Compensation of ₹0.0 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Tejnaksh Healthcare and its competitors.
Is Tejnaksh Healthcare's Stock Based Compensation too high?
Tejnaksh Healthcare's current Stock Based Compensation is ₹0.0 Mil. Overall, Tejnaksh Healthcare has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tejnaksh Healthcare's Stock Based Compensation compare to HCA and THC?
Tejnaksh Healthcare's Stock Based Compensation of ₹0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Tejnaksh Healthcare and its competitors. Tejnaksh Healthcare's current Stock Based Compensation is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tejnaksh Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Tejnaksh Healthcare (BOM:539428) is currently considered Possible Value Trap. The stock's GF Value™ is ₹20.92, compared to a current price of ₹13.25 — trading 36.7% below its estimated fair value. The current Stock Based Compensation is ₹0.0 Mil. Tejnaksh Healthcare's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Tejnaksh Healthcare (BOM:539428), the current Stock Based Compensation is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tejnaksh Healthcare (BOM:539428) Overvalued in 2026?

Based on GuruFocus' analysis, Tejnaksh Healthcare stock appears to be undervalued. The current stock price of ₹13.25 is trading 36.7% below its estimated GF Value™ of ₹20.92. GuruFocus considers Tejnaksh Healthcare to be Possible Value Trap.

Key valuation signals for BOM:539428:

  • Stock Based Compensation: ₹0.0 Mil
  • GF Value™: ₹20.92 vs. price of ₹13.25 (36.7% below fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the BOM:539428 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tejnaksh Healthcare Business Description

Address Institute of Urology, Sakri Road, Dhule, MH, IND, 424 001
Tejnaksh Healthcare Ltd is engaged in the provision of hospital and healthcare services. Geographically, it operates only in India. The company has a single operating segment, namely health care services. The company domains include Urology Hospitals; Nephrology Hospitals; Dental Clinics; Healthcare Equipment, Research and Development and others. It generates maximum revenue from fees charged under contract for inpatient and outpatient hospital services and also includes sale of medical and non-medical items. Hospital services include charges for accommodation, medical professional services, pathology and pharmaceutical goods used in treatments given to patient.
68GF Score

Get the complete analysis for BOM:539428

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.25
Price
₹20.92
GF Value